Search research articles
Contact Us
Filters
Showing results (461-470 of 721) with videos related to
Page
of 73
Sort By:
Neuro-Oncology Advances
|
August 7, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
Teresa Schmidt, Sarina Agkatsev, Jonas Feldheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2016
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients
Wolfgang Peter Fendler, Martin Barrio, Claudio Spick, et al.
The British Journal of Radiology
|
June 25, 2020
Comparison of <sup>18</sup>F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis
Yan Li, Michael Khamou, Benedikt Michael Schaarschmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 22, 2022
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
Caner Civan, Stefan Kasper, Christoph Berliner, et al.
Nuclear Medicine and Biology
|
May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy
Ken Herrmann, Matthias R Benz, Johannes Czernin, et al.
Neurological Research and Practice
|
December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
Andreas Thimm, Saskia Bolz, Michael Fleischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot study
Kim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 28, 2026
Ensuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence
Magdalena Staniszewska, Ralph Hübner, Camilla Locatelli, et al.
Theranostics
|
February 25, 2016
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
Constantin Lapa, Katharina Lückerath, Irene Kleinlein, et al.
Page
of 73
Search research articles
Search
Showing results (461-470 of 721) with videos related to
Sort By:
Page
of 73
Neuro-Oncology Advances
|
August 7, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
Teresa Schmidt, Sarina Agkatsev, Jonas Feldheim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2016
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients
Wolfgang Peter Fendler, Martin Barrio, Claudio Spick, et al.
The British Journal of Radiology
|
June 25, 2020
Comparison of <sup>18</sup>F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis
Yan Li, Michael Khamou, Benedikt Michael Schaarschmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 22, 2022
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
Caner Civan, Stefan Kasper, Christoph Berliner, et al.
Nuclear Medicine and Biology
|
May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2012
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy
Ken Herrmann, Matthias R Benz, Johannes Czernin, et al.
Neurological Research and Practice
|
December 16, 2020
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas
Andreas Thimm, Saskia Bolz, Michael Fleischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 29, 2024
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot study
Kim M Pabst, Riccardo Mei, Katharina Lückerath, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 28, 2026
Ensuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence
Magdalena Staniszewska, Ralph Hübner, Camilla Locatelli, et al.
Theranostics
|
February 25, 2016
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
Constantin Lapa, Katharina Lückerath, Irene Kleinlein, et al.
Page
of 73